Show simple item record

dc.contributor.authorMuñoz-Bravo, Carlos
dc.contributor.authorLozano Lorca, Macarena 
dc.contributor.authorKouiti, Malak
dc.contributor.authorGonzález-Palacios Torres, Carla
dc.contributor.authorBarrios Rodríguez, Rocío 
dc.contributor.authorJiménez Moleón, José Juan 
dc.date.accessioned2023-09-01T10:24:01Z
dc.date.available2023-09-01T10:24:01Z
dc.date.issued2023-06-27
dc.identifier.citationMuñoz-Bravo C, Soler-Iborte E, Lozano- Lorca M, Kouiti M, González-Palacios Torres C, Barrios-Rodríguez R and Jiménez-Moleón JJ (2023) Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis. Front. Cardiovasc. Med. 10:1217748. [doi: 10.3389/fcvm.2023.1217748]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/84185
dc.description.abstractBackground: Despite the fact that several studies have investigated the association between serum copper levels (S-Cu) and the risk of cardiovascular diseases, this relationship remains unclear. The aims of this study were to investigate the association between S-Cu and risk of major adverse cardiovascular events (MACE), including total stroke, ischemic stroke, hemorrhagic stroke, myocardial infarction and cardiovascular mortality, and identify potential sources of results heterogeneity. Methods: We carried out a systematic review and meta-analysis. The selection criteria were: (1) Observational studies (cohort studies, case-control studies and hybrid studies); (2) Studies containing quantitative data about the relationship between S-Cu and risk of MACE; (3) Estimating association measures; and (4) Studies written in English, French or Spanish. Overall pooled Odds ratio (pOR) and 95% confidence intervals (95% CI) of MACE for the highest vs. lowest S-Cu category were calculated using random-effects models. Results: Sixteen studies with a total of 41,322 participants were included in the meta-analysis: 10 prospective cohort studies, 5 nested case-control studies and 1 case-control study. Comparing highest vs. lowest category, high S-Cu levels were associated with total stroke (pOR: 1.49, 95% CI 1.22–1.82; I2=0%, p=0.54), myocardial infarction (pOR: 1.31, 95% CI 1.17–1.46; I2=0.0%, p=0.92) and cardiovascular mortality (pOR: 1.60, 95% CI 1.39–1.86; I2=0.0%, p=0.54). Subgroup analysis showed that studies with a hybrid design had higher risks for cardiovascular mortality (pOR: 3.42, 95% CI 1.98–5.92) and ischemic stroke (pOR: 1.54, 95% CI 1.30–1.83). Conclusion: High S-Cu levels were associated with an increased risk of total stroke, myocardial infarction and cardiovascular mortality. Hybrid studies seems to modify the strength of the association between S-Cu and the risk of cardiovascular mortality and ischemic strokees_ES
dc.language.isoenges_ES
dc.publisherFrontierses_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSerum copperes_ES
dc.subjectCardiovascular diseasees_ES
dc.subjectCardiovascular mortalityes_ES
dc.subjectStrokees_ES
dc.subjectMyocardial infarction es_ES
dc.subjectMeta-analysises_ES
dc.subjectCardiovascular eventses_ES
dc.titleSerum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysises_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3389/fcvm.2023.1217748
dc.type.hasVersionVoRes_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional